China
China's insurers to adjust investment risk controls
China's insurers to adjust investment risk controls
Big state insurers will be directed to raise both the size and proportion of their investments.
Commonwealth Bank to sell stake in Bank of Hangzhou to insurer
The Australian bank could make about A$940m in proceeds.
EV insurance registrations surge in China during December's final week
Nio recorded 6,500 insurance registrations, up 20.37% WoW.
China's medical insurance fund reports surplus in 2024
Basic medical insurance system covered 6.7 billion outpatient settlements.
China cracks down on 300 insurance fraud rings
Over 40 operations have led to investigations into 1,400 cases since April 2024.
Sunshine Life's bancassurance channel fuels profitability
Fitch anticipates the group will continue to prioritise equity investments.
Allianz China, Fudan University partner to boost insurance research
The centre will focus on tech, risk management, and ageing population.
China’s premiums grow sixfold amidst new energy vehicle adoption
But higher claims frequency and repairs challenge profit for some insurers.
Losses from large fire, Typhoon Yagi hit China's proportional treaty results
Loss-free treaties benefitted from notable risk-adjusted reductions, Gallagher Re said.
Munich Re taps new CEO for Beijing operations
He will succeed Steven Chang who will retire in March.
China to tighten medical insurance funds regulation with drug traceability codes
This aims to combat fraudulent activities like the resale of insured medications.
China’s medical insurance to deliver cheaper drugs
It has adjusted the insurance catalogue annually, now covering 3,159 drugs.
China expands basic medical insurance portfolio
The country added 91 new drugs to its medical insurance drug catalogue.
Insurers expect China’s medical cost to increase 11% in 2025
Asia-Pacific is also slated to rise by 12.3% in 2025.
QHR Life Reinsurance drives strong underwriting: AM Best
The company’s capital and surplus increased by 4.3% to $500m in 2023.
Huize plans expansion in Singapore, Philippines
Its Q3 2024 gross written premiums (GWP) reached an all-time high of $290m.
China expands medical insurance drug catalogue to cover 90 rare disease
These treat conditions like hypertrophic cardiomyopathy, and intractable epilepsy.
Commentary
Ageing populations and rising mortality main concerns for life insurers and reinsurers